COR (Cencora, Inc.) Stock Financials & Earnings

CORCencora, Inc.

Mkt Cap$69B

Revenue (TTM)$325.8B

Net Income (TTM)$1.6B

EPS (TTM)$8.32

Free Cash Flow (TTM)$3.6B

Gross Margin3.3%

Op. Margin1.2%

Net Margin0.5%

FCF Margin1.1%

P/S Ratio (TTM)0.2x

P/E Ratio (TTM)42.6x

YoY Rev Growth+7.4%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q2 23	$63.5B	$2.1B	$733M
Q3 23	$66.9B	$1.9B	$568M
Q4 23	$68.9B	$1.9B	$513M
Q1 24	$72.3B	$2.1B	$751M
Q2 24	$68.4B	$2.3B	$869M
Q3 24	$74.2B	$2.1B	$703M
Q4 24	$79.1B	$2.2B	$673M
Q1 25	$81.5B	$2.3B	$792M
Q2 25	$75.5B	$2.6B	$1.0B
Q3 25	$80.7B	$2.7B	$986M
Q4 25	$83.7B	$2.6B	$855M
Q1 26	$85.9B	$2.8B	$1.0B

Revenue Breakdown

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Revenue Segments

Quarter	Animal Health	International Healthcare Solutions	Pharmaceutical Distribution
Q2 23	$1.2B	$6.8B	$55.5B
Q3 23	$1.3B	$7.0B	$58.6B
Q4 23	$1.3B	$7.0B	$60.6B
Q1 24	$1.3B	$7.1B	$63.9B
Q3 24	$1.4B	$7.1B	$65.8B
Q1 25	$1.4B	$7.5B	$72.7B
Q2 25	$1.4B	$7.2B	$66.9B
Q3 25	$1.5B	$7.8B	$71.4B
Q4 25	$1.5B	$7.9B	$74.3B

Revenue by Geography

Quarter	International Healthcare Solutions	U.S. Healthcare Solutions
Q2 23	$6.8B	$56.7B
Q3 23	$7.0B	$59.9B
Q4 23	$7.0B	$61.9B
Q1 24	$7.1B	$65.2B
Q3 24	$7.1B	$67.2B
Q1 25	$7.5B	$74.0B
Q2 25	$7.2B	$68.3B
Q3 25	$7.8B	$72.9B
Q4 25	$7.9B	$75.8B
Q1 26	$7.6B	$76.2B

War Chest

Quarter	Cash	Short-term Investments	Total
Q2 23	$1.6B	$0	$1.6B
Q3 23	$1.5B	$0	$1.5B
Q4 23	$2.7B	$0	$2.7B
Q1 24	$3.0B	$0	$3.0B
Q2 24	$2.2B	$0	$2.2B
Q3 24	$3.4B	$0	$3.4B
Q4 24	$3.2B	$0	$3.2B
Q1 25	$3.3B	$0	$3.3B
Q2 25	$2.1B	$0	$2.1B
Q3 25	$2.3B	$0	$2.3B
Q4 25	$4.4B	$0	$4.4B
Q1 26	$1.8B	$0	$1.8B

Shares Outstanding

Revenue Per Employee

Revenue / Employee